23-05-2023 дата публикации
Номер: CN116143757A
Автор:
ZHOU XINGLU,
LI JIA,
LIU XINGGUO,
ZHOU YUBO,
HU MIAO,
LUO XIAOMIN,
XIE JIANGFENG,
KAN WEIJUAN,
WU YIZHE,
HU XIAOBEI,
SU MINGBO
Принадлежит:
The invention discloses a Bruton's tyrosine kinase degradation agent. The Bruton's tyrosine kinase degradation agent has a structure as shown in a general formula I, or a stereoisomer thereof, or a stereoisomer mixture thereof, or a pharmaceutically acceptable salt and prodrug thereof; the invention also discloses application of the compound and a pharmaceutical composition containing the compound in preparation of drugs for treating diseases related to Bruton's tyrosine kinase, such as B cell or plasma cell proliferative diseases. The compound provided by the invention has strong cell proliferation inhibition activity, can effectively degrade Bruton's tyrosine kinase, and has good liver microparticle metabolism stability and better oral absorption property. The compound can be applied to drugs for treating diseases, obstacles or symptoms which benefit from inhibition or degradation of the activity of Bruton's tyrosine kinase alone or in combination with other drugs.
Подробнее